Black Diamond Therapeutics Inc
Veridion Score
Composite trend over time
Why is BDTX moving today?
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for BDTX.
BDTX insider activity
Black Diamond Therapeutics Inc
2 insiders bought in the last 90 days
Net buying: $111K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-19 | Raman Prakash | Insider | buy | $1.66 | 7,907 | 45,039 | $13K | SEC Form 4 |
| 2026-06-22 | 2026-06-19 | Behbahani Ali | Insider | buy | $1.66 | 8,961 | 102,529 | $15K | SEC Form 4 |
| 2026-03-20 | 2026-03-20 | Raman Prakash | Insider | buy | $2.15 | 6,105 | 37,132 | $13K | SEC Form 4 |
| 2026-03-20 | 2026-03-20 | Behbahani Ali | Insider | buy | $2.15 | 6,919 | 93,568 | $15K | SEC Form 4 |
| 2025-12-15 | 2025-12-12 | Raman Prakash | Insider | buy | $2.76 | 4,665 | 31,027 | $13K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 3 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moBDTX contract awards, year to date.
Public federal awards linked to this ticker.
BDTX lobbying filings, year to date.
Registered lobbying filings matched to Black Diamond Therapeutics Inc.